[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editor's Correspondence
December NaN, 2002

Risk of Myocardial Infarction Associated With Selective COX-2 Inhibitors: Questions Remain—Reply

Arch Intern Med. 2002;162(22):2640. doi:

In reply

We agree completely with the assertions of Drs Goldstein and Jüni and colleagues that the 3 studies recently published in the ARCHIVES regarding naproxen and the risk of acute MI13 do not provide evidence regarding the safety of the selective COX-2 inhibitors, since none of these studies contain patients taking these agents.

First Page Preview View Large
First page PDF preview
First page PDF preview